Evidence map›Paper›PMID 37523399›Full record

ArticlePLoS pathogens2023

Identification of an autotransporter peptidase of Rickettsia rickettsii responsible for maturation of surface exposed autotransporters.

Adam M Nock, Karin Aistleitner, Tina R Clark, Dan Sturdevant, Stacy Ricklefs, Kimmo Virtaneva, Yixiang Zhang, Naila Gulzar, Neelam Redekar, Amitiva Roy and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. mBio · 2024
    Article
  4. PathogenicJournal of bacteriology · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Adam M NockHost-Parasite Interactions Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, NIAID, NIH; Hamilton, Montana, United States of America.
Karin AistleitnerHost-Parasite Interactions Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, NIAID, NIH; Hamilton, Montana, United States of America.
Tina R ClarkHost-Parasite Interactions Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, NIAID, NIH; Hamilton, Montana, United States of America.
Dan SturdevantGenomics Research Section, Research Technologies Branch, Rocky Mountain Laboratories, NIAID, NIH; Hamilton, Montana, United States of America.
Stacy RicklefsGenomics Research Section, Research Technologies Branch, Rocky Mountain Laboratories, NIAID, NIH; Hamilton, Montana, United States of America.
Kimmo VirtanevaGenomics Research Section, Research Technologies Branch, Rocky Mountain Laboratories, NIAID, NIH; Hamilton, Montana, United States of America.
Yixiang ZhangProtein Chemistry Unit, Research Technologies Branch, Rocky Mountain Laboratories, NIAID, NIH; Hamilton, Montana, United States of America.
Naila GulzarIntegrated Data Sciences Section, Research Technologies Branch, NIAID, NIH, Bethesda, Maryland, United States of America.
Neelam RedekarIntegrated Data Sciences Section, Research Technologies Branch, NIAID, NIH, Bethesda, Maryland, United States of America.
Amitiva RoyBioinformatics and Computational Biology Branch, Office of Cyber Infrastructure and Computational Biology, Rocky Mountain Laboratories, NIAID, NIH; Hamilton, Montana, United States of America.
Ted HackstadtHost-Parasite Interactions Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, NIAID, NIH; Hamilton, Montana, United States of America.ORCID 0000-0003-1367-5528
Instituto de Montañas · USRocky Mountain Research (United States) · US

Funding

Infectious Diseases Research Technologies Core - BethesdaZICAI001051 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CHERRY, JAMES · 2009 to 2025
$226.1M
Infectious Diseases Research Technologies Core - RMLZICAI001052 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CHERRY, JAMES · 2009 to 2025
$133.3M
Biology of RickettsiaZIAAI000977 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HACKSTADT, TED · 2009 to 2025
$14.2M
Biology of RickettsiaZ01AI000977 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI HACKSTADT, DAVID (TED) · 2006 to 2008
$1.7M
Intramural NIH HHS Z01 AI000977
6 · The paper itself

Abstract

Members of the spotted fever group rickettsia express four large, surface-exposed autotransporters, at least one of which is a known virulence determinant. Autotransporter translocation to the bacterial outer surface, also known as type V secretion, involves formation of a β-barrel autotransporter domain in the periplasm that inserts into the outer membrane to form a pore through which the N-terminal passenger domain is passed and exposed on the outer surface. Two major surface antigens of Rickettsia rickettsii, are known to be surface exposed and the passenger domain cleaved from the autotransporter domain. A highly passaged strain of R. rickettsii, Iowa, fails to cleave these autotransporters and is avirulent. We have identified a putative peptidase, truncated in the Iowa strain, that when reconstituted into Iowa restores appropriate processing of the autotransporters as well as restoring a modest degree of virulence.

Indexed as

Rickettsia rickettsiiType V Secretion SystemsBacterial Outer Membrane ProteinsPeptide HydrolasesVirulence FactorsBacterial Outer Membrane ProteinsPeptide HydrolasesType V Secretion SystemsVirulence Factors

Identifiers

PMID37523399
PMCPMC10414592
OpenAlexW4385411064

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.